JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2017-12-22
DOI
10.1093/ndt/gfx377
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Filgotinib for the treatment of rheumatoid arthritis
- (2017) Peter C. Taylor et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice
- (2017) Hongyu Zhang et al. KIDNEY INTERNATIONAL
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
- (2017) Peter C. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
- (2017) Roy Fleischmann et al. Arthritis & Rheumatology
- Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
- (2016) Maxime Dougados et al. ANNALS OF THE RHEUMATIC DISEASES
- A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
- (2016) Maryam Afkarian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baricitinib in Patients with Refractory Rheumatoid Arthritis
- (2016) Mark C. Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy
- (2016) Joel M. Kremer et al. Arthritis & Rheumatology
- US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States
- (2015) Rajiv Saran et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- AB0492 Evaluation of Potential Drug-Drug Interactions with Baricitinib
- (2015) C. Payne et al. ANNALS OF THE RHEUMATIC DISEASES
- JAK inhibition and progressive kidney disease
- (2015) Frank C. Brosius et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial
- (2015) Dick de Zeeuw et al. Lancet Diabetes & Endocrinology
- Diabetic Kidney Disease: A Report From an ADA Consensus Conference
- (2014) Katherine R. Tuttle et al. DIABETES CARE
- Renal Outcomes in Patients with Type 1 Diabetes and Macroalbuminuria
- (2014) I. H. de Boer et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serum amyloid A and inflammation in diabetic kidney disease and podocytes
- (2014) Robert J Anderberg et al. LABORATORY INVESTIGATION
- Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
- (2013) M. Afkarian et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and the pathogenesis of diabetic nephropathy
- (2012) Jun Wada et al. CLINICAL SCIENCE
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- Chronic Kidney Disease—A Challenge for All Ages
- (2012) Ian H. de Boer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Urinary MCP-1 and RBP: Independent predictors of renal outcome in macroalbuminuric diabetic nephropathy
- (2012) S.M. Titan et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
- (2012) T. Gohda et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
- (2012) M. A. Niewczas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptome Analysis of Human Diabetic Kidney Disease
- (2011) K. I. Woroniecka et al. DIABETES
- New approaches to the treatment of nephropathy in diabetes
- (2011) Merlin C Thomas et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Therapeutic Modalities in Diabetic Nephropathy: Standard and Emerging Approaches
- (2011) Emaad M. Abdel-Rahman et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase
- (2010) Vishal S. Vaidya et al. KIDNEY INTERNATIONAL
- Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
- (2008) C. C. Berthier et al. DIABETES
- Association of Urinary Inflammatory Markers and Renal Decline in Microalbuminuric Type 1 Diabetics
- (2008) P. P. Wolkow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started